Although there is a growing trend to involve patients in clinical research, specific guiding principles for engaging individuals with Parkinson's disease have not been established. The authors of this Call to Action published ...
May 11, 2022
0
2
After decades of research into the causes and treatment of Parkinson's disease, UC Irvine Health neurologist Dr. Claire Henchcliffe is hopeful that a new cell therapy can finally bring meaningful relief to patients with the ...
May 6, 2022
0
20
A team of researchers affiliated with several institutions in the U.S. has identified a subtype of brain cells that die in Parkinson's patients. In their study, published in the journal Nature Neuroscience, the group used ...
Parkinson's disease is perhaps best known for its movement-related symptoms, particularly tremors and stiffness.
May 4, 2022
0
61
Parkinson's disease and Lewy body dementia belong to a family of neurodegenerative disorders called synucleinopathies because they are caused by the pathological accumulation of protein alpha-synuclein into structures called ...
Apr 29, 2022
0
78
April is Parkinson's Disease Awareness Month, which makes this a good time to learn about the symptoms of Parkinson's disease.
Apr 27, 2022
0
29
The method for assessing occupational pesticide exposure does not appear to influence risk estimates for prostate cancer, non-Hodgkin lymphoma, or Parkinson disease, according to a study published online April 13 in Occupational ...
Apr 18, 2022
0
5
Some of the most troubling features of Parkinson's disease can be reduced by gentle stimulation of the balance organs via the application of electric or thermal currents to nearby parts of the head. This observation, made ...
Apr 11, 2022
0
9
Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal symptoms, a new study ...
Apr 7, 2022
0
10
Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson's disease. Preclinical tests show that the new treatment approach is not only safe ...
Apr 1, 2022
0
45
